Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Kite and Tmunity Therapeutics have announced that the companies have signed an agreement in which […]
Trinity Capital Provides $25 Million Growth Capital To RxAnte
Trinity Capital, a leading provider of diversified financial solutions to growth-stage companies, has announced a […]
Arrowhead Pharmaceuticals Announces $25 Million Milestone Payment from Amgen
Arrowhead Pharmaceuticals has announced a $25M milestone payment from Amgen. This milestone was triggered by […]
OneOncology Partners Add Practices and Physicians to National Platform
OneOncology, a US national platform for independent oncology practices, announced recent significant practice growth and […]
Mestag Therapeutics Appoints Professor Ton Logtenberg as Chair
Mestag Therapeutics, an immunotherapy company harnessing new insights into fibroblast-immune interactions in cancer and inflammatory […]
KKR to Acquire Bushu Pharmaceuticals
KKR, a leading global investment firm, and Bushu Pharmaceuticals have announced the signing of definitive […]
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Scorpion Biological Services has announced it has changed its name to Scorpius BioManufacturing reflecting the […]
CN Bio Appoints Dr Paul Brooks as Chief Executive Officer
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems […]
XtalPi and EDDC Collaborate in AI-empowered Drug Discovery Program for Non-Small Cell Lung Cancer
XtalPi, a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, has announced […]
Synaptogenix Announces Topline Results from NIH-Sponsored Phase 2 Clinical Trial of Bryostatin-1 for Advanced Alzheimer's Disease
Synaptogenix, an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, has announced topline data […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more